COPAXONE for Relapsing-remitting multiple sclerosis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 48 adverse event reports in the FDA FAERS database where COPAXONE was used for Relapsing-remitting multiple sclerosis.
Most Reported Side Effects for COPAXONE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Injection site pain | 163 | 12.9% | 0 | 4 |
| Multiple sclerosis relapse | 136 | 10.7% | 2 | 31 |
| Injection site reaction | 116 | 9.2% | 0 | 1 |
| Injection site mass | 69 | 5.4% | 0 | 0 |
| Injection site erythema | 61 | 4.8% | 0 | 2 |
| Dyspnoea | 58 | 4.6% | 2 | 11 |
| Death | 50 | 3.9% | 50 | 1 |
| Drug ineffective | 45 | 3.6% | 0 | 5 |
| Fatigue | 42 | 3.3% | 0 | 3 |
| Pain | 40 | 3.2% | 1 | 6 |
| Injection site swelling | 36 | 2.8% | 0 | 1 |
| Multiple sclerosis | 35 | 2.8% | 0 | 4 |
| Asthenia | 33 | 2.6% | 1 | 11 |
| Injection site bruising | 33 | 2.6% | 0 | 1 |
| Fall | 31 | 2.4% | 0 | 11 |
Other Indications for COPAXONE
Other Drugs Used for Relapsing-remitting multiple sclerosis
OCRELIZUMAB (15,658)
FINGOLIMOD (8,814)
OFATUMUMAB (3,864)
DIMETHYL (3,638)
NATALIZUMAB (2,749)
INTERFERON BETA-1A (2,058)
GLATIRAMER (1,965)
ALEMTUZUMAB (1,604)
TERIFLUNOMIDE (1,320)
RITUXIMAB (956)